Title:
CANCER TREATING AGENT
Document Type and Number:
Japanese Patent JP2019094340
Kind Code:
A
Abstract:
To provide a cancer treating agent that contains a lymphocyte with PD-1 expression inhibited by genetically modification, as an active ingredient.SOLUTION: A lymphocyte with PD-1 expression inhibited by genetically modification is useful for the treatment of cancer.SELECTED DRAWING: None
More Like This:
Inventors:
HONJO TASUKU
MINATO NAGAHIRO
IWAI YOSHIKO
SHIBAYAMA SHIRO
MINATO NAGAHIRO
IWAI YOSHIKO
SHIBAYAMA SHIRO
Application Number:
JP2019018057A
Publication Date:
June 20, 2019
Filing Date:
February 04, 2019
Export Citation:
Assignee:
ONO PHARMACEUTICAL CO
HONJO TASUKU
HONJO TASUKU
International Classes:
A61K35/17; A61K31/7088; A61K35/14; A61K39/00; A61K39/395; A61P31/00; A61P35/00; A61P35/02; A61P35/04; A61P37/04; C07K16/42; C12N15/02; C12P21/08; C12Q1/02; G01N33/50; G01N33/574
Domestic Patent References:
| JP5885764B2 | 2016-03-15 | |||
| JP2018039835A | 2018-03-15 |
Foreign References:
| WO2001014557A1 | 2001-03-01 | |||
| WO2002000730A2 | 2002-01-03 | |||
| WO2002000692A2 | 2002-01-03 |
Other References:
BLOOD, vol. 97, no. 6, JPN6009036757, 2001, pages 1809 - 1816, ISSN: 0004377406
NATURE MEDICINE, vol. 8, JPN6015008802, June 2002 (2002-06-01), pages 793 - 800, ISSN: 0004377407
FASEB JOURNAL, vol. 16, no. 4, JPN7015002939, April 2002 (2002-04-01), pages 710 - 517, ISSN: 0004377408
NATURE MEDICINE, vol. 8, JPN6015008802, June 2002 (2002-06-01), pages 793 - 800, ISSN: 0004377407
FASEB JOURNAL, vol. 16, no. 4, JPN7015002939, April 2002 (2002-04-01), pages 710 - 517, ISSN: 0004377408
Attorney, Agent or Firm:
Atsushi Aoki
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei